Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant shifts » significant insights (Expand Search), significant benefits (Expand Search)
shifts decrease » sizes decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant shifts » significant insights (Expand Search), significant benefits (Expand Search)
shifts decrease » sizes decrease (Expand Search)
-
2121
-
2122
-
2123
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2124
-
2125
-
2126
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2127
-
2128
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2129
-
2130
-
2131
-
2132
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2133
-
2134
-
2135
-
2136
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2137
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2138
-
2139
-
2140
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: